Contact Us
Contact Us
Contact Us

Investors

Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.

Race Oncology

Race Oncology is a specialty pharmaceutical company focused on rediscovering and rescuing life-saving drugs that can deliver early commercial milestones. Race Oncology’s first asset is Bisantrene, a small molecule Chemotherapy drug that has been evaluated clinically for Acute Myeloid Leukaemia (AML).

ASX: RAC

Price

43.0¢

Latest News

Read All Stories
ASX Announcements



DateTitle
21/02/2018Second Bisantrene Patent Allowed in USDownload
20/02/2018Appendix 4D & Half-Year Financial StatementsDownload
09/02/2018Appendix 3BDownload
09/02/2018Section 708A NoticeDownload
09/02/2018Race Oncology Investor Presentation February 2018Download
31/01/2018Appendix 4C - quarterlyDownload
29/01/2018Notice of Allowance for Bisantrene Patent in USDownload
29/01/2018Notice of Allowance for Bisantrene Patent in USDownload
29/01/2018Notice of Allowance for Bisantrene Patent in USDownload
29/01/2018Notice of Allowance for Bisantrene Patent in USDownload
29/01/2018Notice of Allowance for Bisantrene Patent in USDownload
29/01/2018Notice of Allowance for Bisantrene Patent in USDownload
29/01/2018Notice of Allowance for Bisantrene Patent in USDownload
24/01/2018Race Receives $170k R&D Tax Incentive RefundDownload
24/01/2018Race Receives $170k R&D Tax Incentive RefundDownload
24/01/2018Race Receives $170k R&D Tax Incentive RefundDownload
24/01/2018Race Receives $170k R&D Tax Incentive RefundDownload
24/01/2018Race Receives $170k R&D Tax Incentive RefundDownload
24/01/2018Race Receives $170k R&D Tax Incentive RefundDownload
24/01/2018Race Receives $170k R&D Tax Incentive RefundDownload
11/01/2018Appendix 3BDownload
11/01/2018Section 708A NoticeDownload
11/01/2018Appendix 3BDownload
11/01/2018Section 708A NoticeDownload
11/01/2018Appendix 3BDownload
11/01/2018Section 708A NoticeDownload
11/01/2018Appendix 3BDownload
11/01/2018Section 708A NoticeDownload
11/01/2018Appendix 3BDownload
11/01/2018Section 708A NoticeDownload
11/01/2018Appendix 3BDownload
11/01/2018Section 708A NoticeDownload
11/01/2018Appendix 3BDownload
11/01/2018Section 708A NoticeDownload
04/01/2018Race to Present at JP Morgan Biotech Conference in USDownload
04/01/2018Race to Present at JP Morgan Biotech Conference in USDownload
04/01/2018Race to Present at JP Morgan Biotech Conference in USDownload
04/01/2018Race to Present at JP Morgan Biotech Conference in USDownload
04/01/2018Race to Present at JP Morgan Biotech Conference in USDownload
04/01/2018Race to Present at JP Morgan Biotech Conference in USDownload
04/01/2018Race to Present at JP Morgan Biotech Conference in USDownload

Don't miss important updates

Get the latest news & announcement and stay up-to-date.

© 2017 Race Oncology. Website By Glide Agency